[HTML][HTML] The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID

J Li, Y Zhou, J Ma, Q Zhang, J Shao, S Liang… - … and Targeted Therapy, 2023 - nature.com
There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With …

Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments

R Najafloo, J Majidi, A Asghari… - ACS Chemical …, 2021 - ACS Publications
The occurrence of anosmia, the loss or change in sense of smell, is one of the most common
symptoms of COVID-19 experienced by almost 53% of those affected. Several hypotheses …

[PDF][PDF] Six month follow-up of self-reported loss of smell during the COVID-19 pandemic

C Hopkins, P Surda, LA Vaira, JR Lechien, M Safarian… - Rhinology, 2021 - academia.edu
Introduction: Loss of smell and taste is now recognised as amongst the most common
symptoms of COVID-19 and the best predictor of COVID-19 positivity. Long term outcomes …

[HTML][HTML] Ultramicronized palmitoylethanolamide and luteolin supplement combined with olfactory training to treat post-COVID-19 olfactory impairment: a multi-center …

A Di Stadio, L D'Ascanio, LA Vaira… - Current …, 2022 - ncbi.nlm.nih.gov
Background: Olfactory training is the only evidence-based treatment for post-viral olfactory
dysfunction. Smell disorders after SARS-CoV-2 infection have been attributed to …

COVID-19 related olfactory dysfunction

K Karamali, M Elliott, C Hopkins - Current opinion in …, 2022 - journals.lww.com
COVID-19 related olfactory dysfunction : Current Opinion in Otolaryngology & Head and Neck
Surgery COVID-19 related olfactory dysfunction : Current Opinion in Otolaryngology & Head …

Use of platelet‐rich plasma for COVID‐19–related olfactory loss: a randomized controlled trial

CH Yan, SS Jang, HFC Lin, Y Ma… - … Forum of Allergy & …, 2023 - Wiley Online Library
Introduction The current study evaluated the use of platelet‐rich plasma (PRP), an
autologous blood product with supraphysiologic concentrations of growth factors, in the …

[HTML][HTML] The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients

LA Vaira, C Gessa, G Deiana, G Salzano, F Maglitto… - Life, 2022 - mdpi.com
(1) Background: Persistent olfactory (POD) and gustatory (PGD) dysfunctions are one of the
most frequent symptoms of long-Coronavirus Disease 2019 but their effect on the quality of …

Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study

M Petrocelli, S Cutrupi, G Salzano… - The Journal of …, 2021 - cambridge.org
BackgroundThe long-term recovery rate for coronavirus disease 2019 related
chemosensory disturbances has not yet been clarified. MethodsOlfactory and gustatory …

[HTML][HTML] Therapeutic approaches to the neurologic manifestations of COVID-19

EL Graham, IJ Koralnik, EM Liotta - Neurotherapeutics, 2022 - Elsevier
As of May 2022, there have been more than 527 million infections with severe acute
respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from …

[HTML][HTML] Olfactory recovery following infection with COVID-19: A systematic review

A Jafar, A Lasso, R Shorr, B Hutton, S Kilty - PLoS One, 2021 - journals.plos.org
Olfactory loss has been identified as one of the common symptoms related to COVID-19
infection. Although olfactory loss is recognized, our understanding of both the extent of loss …